GO:0044344 cellular response to fibroblast growth factor stimulus: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044344 describes how a cell changes its state or activity in response to fibroblast growth factor (FGF) stimulation [1, 7].
• FGF signaling is critical for tissue repair, fibrosis, angiogenesis, and cardiac hypertrophy [1, 2, 7].
• Key genes include FGF2, FGFR1, and downstream effectors such as BRD4 and CASP1 [3, 6, 7].
• Dysregulation of this response contributes to heart fibrosis, lung fibrosis, and atherosclerosis [1, 5, 6].
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of FGF response genes [3, 8].
• Methods like RNA-seq, proteomics, and imaging are used to study cellular responses to FGF [3, 8].
Description
The Gene Ontology term GO:0044344, cellular response to fibroblast growth factor stimulus, defines any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fibroblast growth factor stimulus [1, 7]. Fibroblast growth factors (FGFs) are a family of signaling proteins that regulate diverse cellular functions, including proliferation, differentiation, migration, and survival [2, 7]. This response is essential for normal development and tissue homeostasis, but its dysregulation is implicated in numerous pathologies, including fibrosis, cancer, and cardiovascular diseases [1, 3, 5]. Researchers study GO:0044344 to understand how cells interpret FGF signals and how these signals go awry in disease. For example, in cardiac fibroblasts, FGF stimulation triggers activation and extracellular matrix production, contributing to heart fibrosis [1, 3]. In lung fibroblasts, FGF signaling interacts with biomechanical forces and TGF-beta pathways to drive fibrotic responses [5, 8]. Understanding the cellular response to FGF is therefore critical for identifying therapeutic targets and developing interventions. This article provides a comprehensive overview of the ontology, mechanisms, key genes, disease relevance, and research methods associated with GO:0044344.
cellular response to fibroblast growth factor stimulus At A Glance
| GO ID | GO:0044344 |
|---|---|
| GO term | cellular response to fibroblast growth factor stimulus |
| Ontology | biological_process |
| Synonym | cellular response to FGF stimulus |
| Major function | Mediates cellular changes in response to FGF signaling, affecting proliferation, differentiation, migration, and gene expression [1, 7] |
| Related diseases | Cardiac fibrosis, lung fibrosis, atherosclerosis, cancer [1, 5, 6] |
| Key genes | FGF2, FGFR1, BRD4, CASP1, and others [3, 6, 7] |
| Research methods | CRISPR screens, RNA-seq, proteomics, imaging [3, 8] |
What Is GO:0044344?
GO:0044344, cellular response to fibroblast growth factor stimulus, is a biological process term in the Gene Ontology. It encompasses any cellular change that occurs as a result of an FGF stimulus, including alterations in gene expression, cell movement, secretion, enzyme activity, and other cellular activities [1, 7]. This term is a child of response to fibroblast growth factor stimulus and cellular response to growth factor stimulus. It is distinct from the broader response to FGF, as it specifically focuses on processes occurring within a single cell. The definition is based on the QuickGO authoritative data.
Why Is cellular response to fibroblast growth factor stimulus Important in Cell Biology?
GO:0044344 is important because FGF signaling is a fundamental pathway that controls cell behavior in development, tissue repair, and disease. Dysregulated cellular responses to FGF are central to fibrotic disorders, where excessive FGF signaling promotes fibroblast activation and matrix deposition, leading to organ dysfunction [1, 3, 5]. In the heart, FGF2 release after mechanical stress contributes to hypertrophic responses. In lung fibrosis, FGF signaling interacts with biomechanical forces and inflammatory mediators to sustain fibroblast activation [5, 8]. Moreover, FGF signaling influences angiogenesis, and carbohydrate-recognition mechanisms modulate this process. In atherosclerosis, CASP1 upregulation is associated with disease progression, potentially through FGF-related pathways. Thus, understanding GO:0044344 offers insights into disease mechanisms and identifies potential targets for therapeutic intervention.
• Critical for tissue repair and regeneration after injury [1, 7].
• Drives fibrosis in heart, lung, and other organs when dysregulated [1, 5].
• Modulates angiogenesis and vascular remodeling.
• Involved in cardiac hypertrophy and heart failure.
• Linked to atherosclerosis through inflammatory pathways.
• Plays a role in cancer progression via FGF-driven proliferation.
• Interacts with TGF-beta signaling in lung fibrosis.
• Regulated by chromatin modifiers such as BRD4.
• Target for CRISPR-based functional studies [3, 8].
• Provides biomarkers and therapeutic targets for fibrotic diseases [1, 5].
What Happens During cellular response to fibroblast growth factor stimulus?
FGF Binding and Receptor Activation
In simple terms: FGF binds to its receptor on the cell surface, turning on a signaling cascade.
The cellular response to FGF begins when FGF ligands bind to fibroblast growth factor receptors (FGFRs) on the cell membrane. This binding induces receptor dimerization and autophosphorylation, activating intracellular signaling pathways. In cardiac myocytes, mechanical activity can cause release of basic FGF, which then acts in an autocrine or paracrine manner to trigger hypertrophic responses. This step is essential for transmitting the FGF signal into the cell.
Intracellular Signaling Cascades
In simple terms: Activated receptors turn on multiple signaling pathways inside the cell.
Upon activation, FGFRs phosphorylate downstream adaptor proteins, leading to activation of the RAS-MAPK, PI3K-AKT, and PLC-gamma pathways. These cascades alter gene expression and enzyme activity. For instance, in lung fibroblasts, FGF signaling interacts with biomechanical forces and TGF-beta to promote fibrotic gene programs [5, 8]. The specific pathways engaged depend on cell type and context.
Gene Expression and Chromatin Remodeling
In simple terms: Signals reach the nucleus and change which genes are turned on or off.
FGF signaling leads to activation of transcription factors such as ELK1 and FOS, which bind to promoters of target genes. Chromatin remodeling complexes, including BRD4, are recruited to enhance transcription of pro-fibrotic and proliferative genes. In cardiac fibroblasts, BRD4 targeting is dynamically regulated upon FGF stimulation, and its inhibition blunts activation. This step results in long-term changes in cell behavior.
Cellular Outcomes: Proliferation, Migration, and Secretion
In simple terms: The cell changes its behavior, such as dividing, moving, or secreting proteins.
The ultimate outcomes of FGF response include increased cell proliferation, enhanced migration, and secretion of extracellular matrix components. In fibrosis, these outcomes contribute to scar formation. For example, in heart fibrosis, FGF-stimulated fibroblasts produce collagen and other matrix proteins. In angiogenesis, FGF promotes endothelial cell migration and tube formation, a process modulated by carbohydrate-recognition mechanisms. These cellular changes are hallmarks of the FGF response.
Key Genes Involved in GO:0044344 cellular response to fibroblast growth factor stimulus
The following genes are key players in the cellular response to fibroblast growth factor stimulus, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FGF2 | Ligand that binds FGFRs to initiate signaling | Released by cardiac myocytes under mechanical stress; drives hypertrophy |
| FGFR1 | Receptor tyrosine kinase that mediates FGF signaling | Central to FGF response; target for inhibitors |
| BRD4 | Chromatin reader that regulates transcription | Dynamic targeting upon FGF stimulation in cardiac fibroblasts; promotes activation |
| CASP1 | Inflammatory caspase involved in atherosclerosis | High expression associated with atherosclerosis; may intersect FGF pathways |
| TGFB1 | Cytokine that interacts with FGF signaling | Contrasting mechanisms with bleomycin in lung fibrosis |
| COL1A1 | Extracellular matrix protein | Upregulated in fibrosis; marker of FGF-driven fibroblast activation |
| ACTA2 | Smooth muscle actin, myofibroblast marker | Induced by FGF in activated fibroblasts |
| ELK1 | Transcription factor downstream of MAPK | Mediates FGF-induced gene expression |
| FOS | Immediate early transcription factor | Activated by FGF signaling |
| MAPK1 | Kinase in RAS-MAPK pathway | Transmits FGF signals to nucleus |
| PIK3CA | Catalytic subunit of PI3K | Activates AKT pathway downstream of FGFR |
| AKT1 | Serine/threonine kinase | Promotes survival and proliferation in FGF response |
| PLCG1 | Phospholipase C gamma | Generates second messengers upon FGFR activation |
| STAT3 | Transcription factor | Contributes to FGF-induced gene expression |
| NFKB1 | Transcription factor | Links inflammation to FGF signaling |
| VEGFA | Angiogenic factor | Induced by FGF in angiogenesis |
| MMP2 | Matrix metalloproteinase | Remodels extracellular matrix in FGF-driven fibrosis |
| TIMP1 | Inhibitor of metalloproteinases | Regulates matrix turnover in FGF response |
How Is cellular response to fibroblast growth factor stimulus Regulated?
The cellular response to fibroblast growth factor stimulus is tightly regulated at multiple levels. Receptor availability and affinity are modulated by alternative splicing and co-receptors such as heparan sulfate proteoglycans. Intracellularly, negative feedback loops involving Sprouty proteins and MAPK phosphatases attenuate signaling. Chromatin remodeling complexes, such as BRD4, regulate the transcriptional output of FGF signaling; inhibition of BRD4 blunts fibroblast activation in response to FGF. Additionally, cross-talk with other pathways, including TGF-beta and inflammatory signaling, shapes the overall response. In heart fibrosis, eicosanoid degradation pathways modulate the fibrotic response, suggesting lipid mediators also regulate FGF-driven processes. These regulatory mechanisms ensure that FGF responses are context-dependent and self-limiting.
cellular response to fibroblast growth factor stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGF2 | Cardiac hypertrophy and fibrosis | Knockout mouse or overexpression in cardiac myocytes |
| BRD4 | Cardiac fibrosis | Knockout or point mutation in cardiac fibroblasts |
| CASP1 | Atherosclerosis | Overexpression or knockout in vascular cells |
| TGFB1 | Lung fibrosis | Knock-in of constitutively active form in lung fibroblasts |
| COL1A1 | Fibrosis (multiple organs) | Tagged knock-in for imaging matrix deposition |
Cardiac Fibrosis and Heart Failure
Dysregulated cellular response to FGF contributes to cardiac fibrosis, a hallmark of heart failure. In response to mechanical stress, cardiac myocytes release basic FGF, which stimulates fibroblasts to proliferate and secrete extracellular matrix, leading to scar formation. Inhibition of eicosanoid degradation mitigates heart fibrosis, partly by modulating FGF-related pathways. Chromatin targeting by BRD4 in cardiac fibroblasts is dynamically regulated by FGF and promotes activation, making it a potential therapeutic target.
Lung Fibrosis
In lung fibrosis, FGF signaling interacts with biomechanical forces and TGF-beta to drive fibroblast activation and matrix deposition. Bleomycin and TGF-beta-1 induce fibrosis through contrasting initiating mechanisms, but both converge on FGF-related responses. Understanding these pathways is critical for developing anti-fibrotic therapies.
Atherosclerosis and Vascular Disease
FGF signaling influences angiogenesis and vascular remodeling, processes implicated in atherosclerosis. High expression of CASP1 induces atherosclerosis, and CASP1 may intersect with FGF pathways to promote inflammation and plaque formation. Targeting FGF responses could therefore impact vascular disease progression.
From cellular response to fibroblast growth factor stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FGF2 drive cardiac hypertrophy? | FGF2 knockout or overexpression in cardiomyocytes |
| Is BRD4 required for FGF-induced fibroblast activation? | BRD4 knockout or point mutation in cardiac fibroblasts |
| How does CASP1 contribute to atherosclerosis? | CASP1 overexpression or knockout in endothelial cells |
| What is the role of TGF-beta in lung fibrosis? | TGFB1 knock-in or knockout in lung fibroblasts |
| Can eicosanoid degradation inhibition reduce fibrosis? | Knockout of degradation enzymes in heart tissue |
| Does FGF signaling promote angiogenesis? | Endothelial cell-specific FGFR1 knockout |
How to Study the cellular response to fibroblast growth factor stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify FGF-induced transcriptional programs |
| Phosphoproteomics | Kinase activity and signaling nodes | Map FGF-activated pathways |
| Live-cell imaging | Cell migration, proliferation, matrix secretion | Visualize FGF-driven behaviors |
| CRISPR knockout screen | Gene requirement for FGF response | Discover novel regulators |
| ChIP-seq | Chromatin occupancy of transcription factors | Identify BRD4 and other regulators at FGF target genes |
| ELISA | Secreted proteins (e.g., cytokines, matrix) | Quantify FGF-induced secretion |
| Western blot | Protein expression and phosphorylation | Validate signaling activation |
| Flow cytometry | Cell surface markers and proliferation | Assess FGF effects on cell populations |
Transcriptomic Profiling
RNA sequencing (RNA-seq) is widely used to measure global changes in gene expression following FGF stimulation. This method identifies downstream targets and pathways activated in response to FGF. For example, RNA-seq in cardiac fibroblasts treated with FGF reveals upregulation of pro-fibrotic genes and chromatin modifiers like BRD4. Single-cell RNA-seq can resolve heterogeneity in FGF responses across cell populations.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics quantifies protein abundance and post-translational modifications after FGF stimulation. Phosphoproteomics specifically identifies activated kinases and signaling nodes, such as MAPK and AKT. These methods provide a systems-level view of the FGF response.
Imaging and Live-Cell Analysis
Fluorescence microscopy and live-cell imaging track cellular behaviors such as migration, proliferation, and matrix secretion in response to FGF. For instance, imaging of fluorescently tagged collagen can visualize matrix deposition by activated fibroblasts. These techniques complement molecular assays by providing spatial and temporal information.
CRISPR-Based Functional Genomics
CRISPR knockout and activation screens enable unbiased discovery of genes required for or modulating the FGF response. Libraries targeting kinases, transcription factors, or chromatin regulators can identify novel components. For example, CRISPR screening has been used to study fibroblast activation and fibrosis [3, 8].
How CRISPR Can Be Used to Study GO:0044344 cellular response to fibroblast growth factor stimulus
Knockout
CRISPR knockout (KO) is used to delete genes involved in the cellular response to FGF, such as FGF2, FGFR1, or BRD4, to determine their necessity. For example, BRD4 KO in cardiac fibroblasts abolishes FGF-induced activation, demonstrating its essential role. KO models are valuable for validating causal relationships.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to abrogate specific phosphorylation sites. For instance, mutating key residues in FGFR1 can block its kinase activity, revealing downstream effects. This approach fine-tunes gene function without full deletion.
Knock-in
Knock-in of reporter tags (e.g., GFP) or disease alleles allows visualization and functional study of FGF response genes. Tagged knock-in of COL1A1 enables tracking of matrix deposition in live cells. Knock-in of constitutively active mutants can model gain-of-function states.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to increase expression of FGF ligands or receptors, mimicking hyperactive signaling. Overexpression of FGF2 in cardiomyocytes induces hypertrophy. This approach helps identify sufficiency in driving FGF responses.
How EDITGENE Supports cellular response to fibroblast growth factor stimulus Research
Researchers studying cellular response to fibroblast growth factor stimulus-related genes often need to determine whether a candidate gene is causally involved in the response or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies, from knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for cellular response to fibroblast growth factor stimulus research.
Frequently Asked Questions About cellular response to fibroblast growth factor stimulus
What is GO:0044344?
GO:0044344 is the Gene Ontology term for cellular response to fibroblast growth factor stimulus, describing any cellular change resulting from FGF stimulation [1, 7].
What genes are involved in cellular response to fibroblast growth factor stimulus?
Key genes include FGF2, FGFR1, BRD4, CASP1, and downstream effectors like MAPK1 and AKT1 [3, 6, 7].
How does FGF signaling cause fibrosis?
FGF signaling activates fibroblasts to proliferate and secrete extracellular matrix, leading to scar tissue formation in organs like heart and lung [1, 5].
What diseases are associated with dysregulated FGF response?
Cardiac fibrosis, lung fibrosis, atherosclerosis, and cancer are linked to abnormal FGF signaling [1, 5, 6].
What methods are used to study cellular response to FGF?
Common methods include RNA-seq, phosphoproteomics, live-cell imaging, and CRISPR screens [3, 7].
Can CRISPR be used to study FGF response genes?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect gene function in FGF signaling [3, 8].
What is the role of BRD4 in FGF response?
BRD4 is a chromatin reader that is dynamically recruited to genes upon FGF stimulation and is required for fibroblast activation.
How does mechanical stress influence FGF release?
Mechanical activity can cause transient membrane permeability and release of basic FGF from cardiac myocytes, triggering hypertrophic responses.
What is the difference between FGF and TGF-beta in fibrosis?
FGF and TGF-beta are distinct but interacting pathways; both contribute to fibrosis through different initiating mechanisms.
How can I model FGF-driven fibrosis in the lab?
You can use CRISPR knockout or overexpression of FGF2, FGFR1, or BRD4 in fibroblasts, combined with RNA-seq and imaging [1, 3].
Conclusion
The cellular response to fibroblast growth factor stimulus (GO:0044344) is a fundamental biological process that governs how cells react to FGF signals, with profound implications for development, tissue repair, and disease. Dysregulation of this response underlies fibrosis, cardiovascular disease, and cancer, making it a critical area of research. Advances in CRISPR-based models and multi-omics technologies are accelerating the discovery of key regulators and therapeutic targets. EDITGENE provides comprehensive services to support these efforts, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Rubino M et al.. 2023. Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart.. Circ Res 132(1):10-29 PMID: 36475698
- 2. Nangia-Makker P et al.. 2000. Carbohydrate-recognition and angiogenesis.. Cancer Metastasis Rev 19(1-2):51-7 PMID: 11191063
- 3. Stratton MS et al.. 2019. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.. Circ Res 125(7):662-677 PMID: 31409188
- 5. Nho RS et al.. 2022. Biomechanical Force and Cellular Stiffness in Lung Fibrosis.. Am J Pathol 192(5):750-761 PMID: 35183510
- 6. Li Y et al.. 2024. High expression of CASP1 induces atherosclerosis.. Medicine (Baltimore) 103(16):e37616 PMID: 38640260
- 7. Kaye D et al.. 1996. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.. J Clin Invest 97(2):281-91 PMID: 8567946
- 8. D'Alessandro N et al.. 2025. Two roads to fibrosis: Contrasting initiating mechanisms of Bleomycin and TGFβ-1 in lung fibroblasts.. Toxicology 517:154233 PMID: 40645554
